| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $112.8M | +254.6% |
| SG&A Expense | $30.3M | +35.8% |
| Operating Income | -$143.1M | -164.4% |
| Pre-tax Income | -$121.0M | -175.0% |
| Income Tax | $282K | +199.0% |
| Net Income | -$118.9M | -230.3% |
| EPS (Basic) | -$1.89 | -158.9% |
| EPS (Diluted) | -$1.89 | -158.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $180.4M | -60.0% |
| Current Assets | $474.3M | -7.8% |
| Total Assets | $477.9M | -9.2% |
| Current Liabilities | $22.5M | +125.4% |
| Total Liabilities | $24.5M | +88.1% |
| Stockholders' Equity | $446.8M | -9.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$116.6M | -172.5% |
| Capital Expenditures | $520K | +82.5% |
| Investing Cash Flow | -$205.6M | -716.4% |
| Financing Cash Flow | $51.3M | -89.3% |
| Free Cash Flow | -$117.1M | -171.9% |